Can Oral Contraceptive Pills Cause Musculoskeletal Side Effects?
Yes, oral contraceptive pills can cause musculoskeletal side effects, primarily affecting muscle recovery, bone density, and potentially muscle growth, though acute muscle strength appears largely unaffected.
Key Musculoskeletal Effects
Impaired Muscle Recovery and Growth
- OCPs significantly impair muscle recovery after exercise-induced muscle damage, with studies showing greater decreases in muscle strength and elevated creatine kinase levels in OCP users compared to non-users 1.
- Women using OCPs demonstrate reduced lean mass gains during resistance training (2.1% vs 3.5% in non-users, representing 1.0 kg vs 1.6 kg gain), particularly with medium-to-high androgenicity progestins 2.
- The creatine kinase response following eccentric exercise is significantly augmented in OCP users (962 ± 968 U/L vs 386 ± 474 U/L in non-users) 3.
Mechanism Behind Muscle Effects
- OCPs alter the anabolic-catabolic hormone balance by lowering DHEA, DHEAS, and IGF-1 levels while increasing cortisol 2.
- Despite impaired recovery, acute muscle strength remains unchanged in most studies, though general muscle growth and Type I fiber growth may increase in a dose-dependent manner 4.
- Muscle protein synthesis rates are not affected by OCP phase (active vs inactive pill weeks), suggesting the effects are related to overall hormonal suppression rather than cyclical variation 5.
Bone Health Concerns
- Depot medroxyprogesterone acetate (DMPA) should be avoided in patients at risk for osteoporosis, as highlighted in the 2020 American College of Rheumatology guidelines 6.
- This represents the most clinically significant musculoskeletal concern for long-term morbidity.
Tendon and Ligament Effects
- Tendon stiffness remains unchanged with OCP use, though size adaptation to load may increase 4.
- Higher quality evidence suggests OCPs may decrease ACL injury risk and ACL laxity, potentially offering a protective effect against soft tissue injuries 7.
Clinical Implications
For Athletic Performance
- Women engaged in high-performance training may experience disadvantageous effects due to reduced muscle regeneration capacity 4.
- The negative impact on recovery is more pronounced than effects on baseline strength, making this particularly relevant for athletes with frequent training sessions 1.
For General Population
- Most women using OCPs for contraception will not notice significant musculoskeletal symptoms in daily activities, as acute muscle strength is preserved 4, 1.
- The effects become clinically relevant primarily in contexts of resistance training or high-intensity exercise programs 2.
Important Caveats
- The evidence quality is moderate-to-serious risk of bias across most studies, making definitive conclusions challenging 1.
- Effects appear dose-dependent and vary by progestin type, with medium-to-high androgenicity progestins showing more pronounced negative effects on muscle gains 2.
- Serum estrogen levels are significantly lower in OCP users (209 ± 115 pg/mL vs 433 ± 147 pg/mL in non-users), which likely contributes to the observed effects 3.